11 July 2025

Last updated: Thursday 10 July 2025

Research Directory

How Innate Pharma turned a threat into an opportunity

Wellcome Trust rises to the antibiotic challenge

Cell Medica takes a new approach to personalised medicine

Oxford Capital Partners assesses the funding outlook

How Ablynx uses the llama to create antibodies

Are patent backlogs creating an unequal playing field?

EMEA prepares for advanced therapies

Making sure that pharma's product pipelines are never empty

How first-in-man trials could be made safer

Medigene moves further into oncology